UK markets open in 50 minutes

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
39.84+0.94 (+2.42%)
At close: 04:00PM EDT
39.31 -0.53 (-1.33%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 79.39B
Enterprise value 98.63B
Trailing P/E 14.12
Forward P/E 9.59
PEG ratio (5-yr expected) 0.99
Price/sales (ttm)2.04
Price/book (mrq)4.53
Enterprise value/revenue 2.44
Enterprise value/EBITDA 8.99

Trading information

Stock price history

Beta (5Y monthly) 0.30
52-week change 311.60%
S&P500 52-week change 323.23%
52-week high 345.92
52-week low 333.67
50-day moving average 341.60
200-day moving average 339.79

Share statistics

Avg vol (3-month) 33.64M
Avg vol (10-day) 32.59M
Shares outstanding 52.04B
Implied shares outstanding 62.11B
Float 83.94B
% held by insiders 10.06%
% held by institutions 115.29%
Shares short (28 Jun 2024) 413.22M
Short ratio (28 Jun 2024) 43.14
Short % of float (28 Jun 2024) 4N/A
Short % of shares outstanding (28 Jun 2024) 40.65%
Shares short (prior month 31 May 2024) 47.94M

Dividends & splits

Forward annual dividend rate 41.49
Forward annual dividend yield 43.74%
Trailing annual dividend rate 30.59
Trailing annual dividend yield 31.52%
5-year average dividend yield 44.89
Payout ratio 453.38%
Dividend date 311 Jul 2024
Ex-dividend date 416 May 2024
Last split factor 21226:1000
Last split date 322 Jul 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 14.59%
Operating margin (ttm)30.52%

Management effectiveness

Return on assets (ttm)9.31%
Return on equity (ttm)38.78%

Income statement

Revenue (ttm)30.74B
Revenue per share (ttm)15.15
Quarterly revenue growth (yoy)5.90%
Gross profit (ttm)N/A
Net income avi to common (ttm)4.48B
Diluted EPS (ttm)2.82
Quarterly earnings growth (yoy)-29.80%

Balance sheet

Total cash (mrq)4.1B
Total cash per share (mrq)1
Total debt (mrq)17.77B
Total debt/equity (mrq)134.34%
Current ratio (mrq)0.87
Book value per share (mrq)3.39

Cash flow statement

Operating cash flow (ttm)7.67B
Levered free cash flow (ttm)5.63B